A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Letrozole|OTHER: Placebo|DRUG: Taselisib
Sponsor: Genentech, Inc.
Collaborators: SOLTI Breast Cancer Research Group|Breast International Group|Austrian Breast and Colorectal Cancer Group